Fulgent Genetics Inc
NASDAQ:FLGT
Fulgent Genetics Inc
Research & Development
Fulgent Genetics Inc
Research & Development Peer Comparison
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Fulgent Genetics Inc
NASDAQ:FLGT
|
Research & Development
-$41.4m
|
CAGR 3-Years
-53%
|
CAGR 5-Years
-50%
|
CAGR 10-Years
N/A
|
|
DaVita Inc
NYSE:DVA
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Quest Diagnostics Inc
NYSE:DGX
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
CVS Health Corp
NYSE:CVS
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Cigna Corp
NYSE:CI
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Laboratory Corporation of America Holdings
NYSE:LH
|
Research & Development
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Fulgent Genetics Inc's Research & Development?
Research & Development
-41.4m
USD
Based on the financial report for Dec 31, 2023, Fulgent Genetics Inc's Research & Development amounts to -41.4m USD.
What is Fulgent Genetics Inc's Research & Development growth rate?
Research & Development CAGR 5Y
-50%
Over the last year, the Research & Development growth was -43%. The average annual Research & Development growth rates for Fulgent Genetics Inc have been -53% over the past three years , -50% over the past five years .